IP Library Granted Patent US 10,639,437
Granted Patent B2
US 10,639,437 · App. 14/694,300 · Granted May 5, 2020

Delivery devices

Inventors: Per Gisle Djupesland (Oslo, NO); Rune Harald Gaarder (Oslo, NO); Sébastien Lamolle (Oslo, NO)
Assignee: OptiNose AS
A61M15/0098A61M15/0021A61M15/0023A61M15/0028A61M15/0035A61M15/0041A61M15/08A61M2202/04A61M2202/064A61M2205/073A61M2206/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,639,437
App. No.
14/694,300
Granted
May 5, 2020
Kind
B2
Abstract

A delivery device for and method of delivering a metered amount of substance, the delivery device comprising: a mouthpiece through which a user in use exhales; an outlet through which substance is in use delivered; a housing fluidly connected to the mouthpiece and the outlet, such that exhalation by the user through the mouthpiece creates an air flow through the housing and from the outlet; and a substance-dispensing unit which is disposed within the housing and operative to dispense a metered amount of substance into an entraining air flow as created through the housing.

Claims (18)

1. A delivery device for delivering a metered amount of a substance, the delivery device comprising:

a mouthpiece unit including a mouthpiece through which a user can in use exhale;

an outlet unit through which the substance is in use delivered;

a substance-supply unit which is actuatable to deliver the substance; and

a body unit in which the substance-supply unit is movably disposed between a storage configuration and an operative configuration;

wherein the mouthpiece unit is coupled to the substance-supply unit, the substance-supply unit being movable between the storage and operative configurations by movement of the mouthpiece unit;

wherein the substance-supply unit slides in a substantially linear direction, longitudinally within the body unit from the storage configuration to the operative configuration when the substance-supply unit is moved into the operative configuration; and

wherein the mouthpiece is articulated to the substance-supply unit and movable relative to the body unit when the substance-supply unit is in the operative configuration.

2. The delivery device of claim 1 , wherein the outlet unit is integrally formed with the body unit.

3. The delivery device of claim 1 , wherein the body unit comprises a housing which includes a cavity in which the substance-supply unit is slideably disposed.

4. The delivery device of claim 1 , wherein:

the mouthpiece unit is fluidly connected to the substance-supply unit; and

the substance-supply unit is actuatable in response to exhalation by the user through the mouthpiece.

5. The delivery device of claim 1 , wherein the substance-supply unit is actuatable in response to movement of the mouthpiece.

6. The delivery device of claim 1 , wherein the outlet unit is a nosepiece and the delivery device is a nasal delivery device for delivering the substance to a nasal airway of the user.

7. The delivery device of claim 1 , wherein the substance is a particulate substance.

8. The delivery device of claim 1 , wherein the substance is a powdered substance.

9. The delivery device of claim 1 , wherein the substance is a liquid substance.

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 71337/0132 Recorded Mar 17, 2026
From: OAKTREE FUND ADMINISTRATION, LLC
To: OPTINOSE, INC.
Reel/Frame 075101/0804 →
PATENT SECURITY AGREEMENT Recorded Mar 16, 2026
From: OPTINOSE, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 075111/0018 →
SECURITY INTEREST Recorded May 22, 2025
From: OPTINOSE, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071337/0132 →
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 8, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069848/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2017
From: DJUPESLAND, PER GISLE; GAARDER, RUNE HARALD; LAMOLLE, SEBASTIEN
To: OPTINOSE AS
Reel/Frame 042709/0561 →